Drawing for OPM

USPTO serial 98641117

OPM

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
COUEY,JORDAN ELIZABETH
Law office
TMO LAW OFFICE 130

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with OPM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shanshan Liang

2104 Delta Way, Unit 1Tallahassee, FL 32303United States

Goods and services

ClassDescriptionStatusFirst use
005organotherapy preparations for medical use; biochemical pharmaceutical preparations for medical use; Medicinal serums; pharmaceutical chemical preparations, namely, for medical use; medical stem cells; medical chemical preparations for medical purposes; chemical reagents for medical or veterinary use; microbiological tissue cultures for medical or veterinary use; immunoassay reagents for medical use; biological preparations for medical use in cell cultures; biological tissue cultures for medical use; diagnostic preparations for medical use; Pharmaceutical active ingredients for use in the manufacture of drugs.ACTIVE—
041arrange and organize conferences, namely, arranging and conducting of conferences in the field of biotechnology, pharmaceutical sciences, and biopharmaceutical development; arrange and organize training sessions, namely, arranging and conducting of training seminars in the field of biotechnology research, pharmaceutical manufacturing and cell culture technology; arrange and organize academic seminars, namely, arranging and conducting of educational seminars in the field of biopharmaceutical research, drug development, and pharmaceutical sciences; arrange and organize expert discussions, namely, arranging and conducting of symposiums in the field of biopharmaceutical development, biologics manufacturing, and pharmaceutical innovation; arrange and organize specialized workshops, namely, arranging and conducting of specialized workshops in the field of cell culture media technology, bioprocess development, and biotechnology applicationsACTIVE—
042chemical research services; gene screening in the nature of genetic testing for scientific research purposes; information technology consulting relating to installation, maintenance and repair of computer software; scientific laboratory services; scientific research and development; scientific research in the nature of conducting clinical trials for others; biological research; research and development of new products for others; drug evaluation in the nature of pharmaceutical product evaluation; pharmaceutical researchACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jan 9, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 9, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 22, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 11, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 11, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 11, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 22, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Apr 22, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Feb 11, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 24, 2025DOCKASSIGNED TO EXAMINER—
Jan 15, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 10, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance